March 23, 2000

Company Press Release

Galileo Labs CEO Predicts Emerging Trends and Technologies Impacting America's Wellness Sector at Vlab Forum

Good Morning America's Dr. Nancy Snyderman to Moderate March 28 Event for Industry Leaders

Santa Clara, CA, March 23, 2000 – The MIT/Stanford Venture Lab (Vlab) forum, one of the nation's most prestigious technology forums, is bringing together an all-star panel of leading health care experts to discuss new paradigms impacting America's wellness.

Moderated by Dr. Nancy Snyderman, the panel will include Dr. Susan Love, the nation's foremost expert on breast cancer, Elizabeth Browning, president, Dupont Consumer Health, and Russ Landon of Adams, Harkness & Hill, an investment banking firm specializing in the “Healthy Living'' sector. Dr. Guy Miller, M.D., Ph.D., CEO of Galileo Laboratories, Inc. will be the featured speaker. His presentation entitled “Technology and Competition for America's Wellness Sector'' will address how advanced technologies and evidence-based nutritional products are revolutionizing the way consumers meet their healthcare and wellness needs.

“Wellness is not about fixing a problem,'' according to Dr. Snyderman, medical correspondent for ABC News, 20/20 and Good Morning America. “It's about preventing problems and providing a better quality of life. American's are becoming increasingly aware of concerns regarding wellness and disease prevention.''

As a practicing physician Dr. Miller is also committed to helping consumers enhance their health and well being. As the founder and CEO of Galileo Laboratories he is applying biotechnology and pharmaceutical tools to produce evidence-based nutritionals and drugs. “Nutritional products manufacturers and consumers alike share a common interest in the highest quality nutritional products possible,'' stated Dr. Miller. “With Galileo's proprietary technologies we are addressing that need today.''

About Galileo Laboratories

Galileo Laboratories, Inc. is a life science company involved in the discovery and development of therapeutic compounds for the prevention and treatment of diseases caused by oxidative and metabolic stress. The company develops these compounds as functional food ingredients, complimentary medicines, medical foods and pharmaceuticals. Galileo has recently entered into strategic alliances with industry leaders such as Warner-Lambert and Procter & Gamble.

About MIT/Stanford Venture Laboratory

The MIT/Stanford Venture Lab forum is one of the nation's premier high-tech forums. Founded as a non-profit organization by the MIT Enterprise Forum, the Stanford Office of Technology Licensing and the Alumni Association of the Graduate School of Business, Vlab's mission is to foster the growth and success of entrepreneurial ventures by connecting emerging ideas, technology and people.

Contact

Peter Leighton, Vice President Marketing
Galileo Laboratories, Inc.
408.654.5830 x 107
pleighton@GalileoLabs.com

Anne-Lee Tomczyk
MIT Stanford Venture Laboratory
408.323.2246
Info@vlab.org
www.vlab.org